home / stock / medi:cc / medi:cc news

MEDI:CC News and Press, WELLBEING DIGITAL SCIENCES INC. From 09/26/22

Stock Information
Company Name: WELLBEING DIGITAL SCIENCES INC.
Stock Symbol: MEDI:CC
Market: AQNC
Website: wellbeingdigital.co
Menu
MEDI:CC MEDI:CC Quote MEDI:CC Short MEDI:CC News MEDI:CC Articles MEDI:CC Message Board
Get MEDI:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
MEDI:CC - Wellbeing Subsidiary KGK Science Opens New Clinical Research Center to Reimagine a Healthier Future

New Clinical Facility in London, Ontario Accelerates Research and Innovation Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company ...
MEDI:CC - Wellbeing Digital to Participate in the Microdose Psychedelic Capital Conference

Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including...

MEDI:CC - Wellbeing Digital Reports Financial Results for the Fourth Fiscal Quarter

Revenue Exceeded $1.1 Million for the Period Ended July 31, 2022 Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on t...

MEDI:CC - Wellbeing Subsidiary KGK Science Announces AKL No Objection Status for ProGo® Branded Ingredient from FDA

KGK client, Hofseth Biocare ASA, is yet again part of an Exclusive Short-List of Companies to Have Successfully Notified FDA while receiving a No Objection Acknowledgement (AKL) Letter for ProGo® Bioactive Peptides Wellbeing Digital Sciences Inc. (“ Wellbeing&#...
MEDI:CC - Wellbeing Subsidiary IRP Health Toronto Location Approved by Veterans Affairs Canada for Its Reactivation Program

IRP Health continues to focus on enriching the lives of its patients and raising the bar for outstanding mental healthcare Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an...

MEDI:CC - Wellbeing Corporate Update in a Letter from the CEO to its Shareholders

Subsidiary KGK has $17 million of future revenue as of end of June, which we project to complete in the next 12 to 18 months through our research and consulting contracts, with $10-11 million to be billed in the next 12 months Wellbeing Digital Sciences Inc. (“ ...

MEDI:CC - Wellbeing Digital Sciences Inc. Changes Year-End

VANCOUVER, British Columbia, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“ Wellbeing ” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ) has filed the required notice to change its financial year end from July 3...
MEDI:CC - Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase II Clinical Trial

KGK to conduct Phase II clinical trial to test the efficacy of psilocybin on treatment resistant PTSD Wellbeing Digital Sciences Inc. (“ Wellbeing ” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-ba...

MEDI:CC - Wellbeing Digital Sciences Announces the Appointment of Natalie Dolphin as VP of Marketing and Investment Relations

VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“ Wellbeing ” or the “ Company ”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and impl...

MEDI:CC - Wellbeing Digital Sciences Announces Q3 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, June 16, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“ Wellbeing ” or the “ Company ”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and impl...
Previous 10 Next 10